about
S100A6 binds to annexin 2 in pancreatic cancer cells and promotes pancreatic cancer cell motilityDual-color proteomic profiling of complex samples with a microarray of 810 cancer-related antibodiesThe unfolded protein response regulator GRP78 is a novel predictive biomarker in colorectal cancer.Somatic mutations in exocrine pancreatic tumors: association with patient survivalThe expression of S100A8 in pancreatic cancer-associated monocytes is associated with the Smad4 status of pancreatic cancer cellsTERT gene harbors multiple variants associated with pancreatic cancer susceptibilityDiagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis by measurement of microRNA abundance in blood and tissuecAMP inhibits migration, ruffling and paxillin accumulation in focal adhesions of pancreatic ductal adenocarcinoma cells: effects of PKA and EPAC.Application of laser capture microdissection combined with two-dimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal adenocarcinoma.Confounding effect of obstructive jaundice in the interpretation of proteomic plasma profiling data for pancreatic cancer.Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trial.Smad4 loss is associated with fewer S100A8-positive monocytes in colorectal tumors and attenuated response to S100A8 in colorectal and pancreatic cancer cells.Serum cytokine biomarker panels for discriminating pancreatic cancer from benign pancreatic disease.Pancreatic cancer susceptibility loci and their role in survival.Serum CA19-9 is significantly upregulated up to 2 years before diagnosis with pancreatic cancer: implications for early disease detection.Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer.Gene therapy for pancreatic cancer--current and prospective strategies.Biology and management of pancreatic cancer.Tetracycline-inducible protein expression in pancreatic cancer cells: effects of CapG overexpression.Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy.Pancreatic cancer cells overexpress gelsolin family-capping proteins, which contribute to their cell motilityIdentification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic AdenocarcinomaTrials of gene therapy for pancreatic carcinoma.Proteomic analysis of pancreatic cancer stem cells: Functional role of fatty acid synthesis and mevalonate pathways.Proteomic technologies and their application to pancreatic cancer.The role of inflammatory cells in fostering pancreatic cancer cell growth and invasionUHRF1 regulation of the Keap1-Nrf2 pathway in pancreatic cancer contributes to oncogenesisImmunobiological effects of gemcitabine and capecitabine combination chemotherapy in advanced pancreatic ductal adenocarcinomaOverexpression of Mos, Ras, Src, and Fos inhibits mouse mammary epithelial cell differentiation.Decreased Serum Thrombospondin-1 Levels in Pancreatic Cancer Patients Up to 24 Months Prior to Clinical Diagnosis: Association with Diabetes Mellitus.iTRAQ reveals candidate pancreatic cancer serum biomarkers: influence of obstructive jaundice on their performance.New treatment options for advanced pancreatic cancer.Pancreatic cancer: proteomic approaches to a challenging disease.Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer riskCurrent status of GV1001 and other telomerase vaccination strategies in the treatment of cancer.The pancreatic cancer proteome - recent advances and future promise.Pancreatic cancer in 2010: new insights for early intervention and detection.Nanotechnology advances in upper gastrointestinal, liver and pancreatic cancer.New biomarkers and targets in pancreatic cancer and their application to treatment.Biomarkers for early diagnosis of pancreatic cancer.
P50
Q24311937-C6051E5F-D312-496A-97D5-84AB5A7524C1Q24604179-CF46FFAE-F63F-4A02-91B2-792EDA35E187Q27852108-60056147-F5CC-422D-8227-B75BCEB8F984Q27852155-8AAAEEE3-431E-4264-9872-06FE83BEF32EQ28299932-782B2493-20EC-4E21-A96B-2E8ACB292104Q28386653-D87A9EBF-D305-448B-B149-0B77AA4AF896Q28730615-B0E81D18-43BF-4BE3-8986-9F881259DEC9Q30566337-8AB69A56-AC98-41E4-9FE6-5DD8D8CCD840Q31027168-FE7895D7-BC0D-4F96-AA0C-B7DD44C91405Q33389438-625278E0-982F-4BE4-8D54-A9AFF748DDEFQ33439829-9DB35A50-A088-44FB-ABCE-BED0A68F2873Q33630110-391FD28F-2A84-4516-9B18-4FB194367B18Q33655712-ECD70888-6A10-43FC-913E-F393B77C89BBQ34085823-D9D92492-D94C-4C46-AC32-F08BE7A71D40Q34275247-D3A74F00-18A6-4EB2-9431-C7E4E1084248Q34314018-758B4DFE-3343-42E1-9976-E40F411A2E22Q34321686-C9DFDCC2-4EDD-4419-84E3-9AA45E05B68DQ34649019-BDC3353A-9A6A-4892-8180-CD1B7B65861AQ34863173-44807D0E-428A-44E3-B5EF-7EC9F3B72951Q34993085-8D85FB5A-AB64-4065-B4A0-CDF1B3CDF4A2Q35761260-45D5E67D-55CC-4FFE-AD6A-BA27214FD1CDQ35964357-9382D03E-9E47-46EB-8648-153D57439BA3Q36137459-8C6BE0F7-4CD8-42B6-BE33-478E18C3E172Q36164569-4E46969C-75E0-4EEC-9D22-2B4E348C6053Q36168426-1E4F818A-B949-4273-A014-CB50B27A8EEFQ36202213-57676B80-DDC9-46F1-AE3F-865809C4CB64Q36536562-EBE50AFA-CA5B-4AC5-A391-FCC05C967314Q36661995-7A22C7CD-406A-4BE2-BFE8-B3DD5F7A59EDQ36699640-6F0D5012-A34B-43B0-86A7-866362BEA986Q36763283-063619E4-CFD3-4C59-8742-F87D33C5F0FBQ36857512-1DCB43BB-7531-4E22-A41A-D8B20AC794CDQ37345841-222261DB-CA5F-429D-978A-9808C27A3BE1Q37573301-562225F9-F311-4FB0-B5FC-6FBCC266A643Q37636741-D9582B63-D765-42F9-85A0-4C5291393913Q37785948-A1DCBF56-E1C4-45CA-9C42-5E0D5A67F5CFQ37817143-3BE3D165-5D8A-4971-9027-36B5736E5047Q37835701-958B92CC-967D-4776-A09E-C2EFE7309C6AQ38014497-9CAF1531-A875-428A-8C45-9AB02B977030Q38021692-94D7E745-C716-45DC-A1AA-2D6C8D030783Q38265405-CEEFEA66-B8BC-4142-A8AC-61F46514A743
P50
description
researcher ORCID ID = 0000-0002-0104-8992
@en
wetenschapper
@nl
name
Eithne Costello
@ast
Eithne Costello
@en
Eithne Costello
@es
Eithne Costello
@nl
type
label
Eithne Costello
@ast
Eithne Costello
@en
Eithne Costello
@es
Eithne Costello
@nl
prefLabel
Eithne Costello
@ast
Eithne Costello
@en
Eithne Costello
@es
Eithne Costello
@nl
P1153
17833870500
P21
P31
P496
0000-0002-0104-8992